Physician profile
Monica Smith
NPI 1467770883
$3,937.45
in general payments reported to CMS, 2019-2025
12 companies · $39.58 in 2025
The $39.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $157 · 2021: $1,389 · 2022: $134 · 2023: $1,688 · 2024: $160 · 2025: $39.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Travel and Lodging: $850 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.22 |
| Travel and Lodging | $849.60 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,701.23 | 2019-2023 | Da Vinci Surgical System |
| Vanda Pharmaceuticals INC. | $859.07 | 2020-2024 | Hetlioz, Fanapt |
| Minerva Surgical, INC | $120.04 | 2019 | |
| Astellas Pharma US INC | $61.48 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $54.53 | 2023-2024 | |
| Abbvie INC. | $34.25 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.04 | 2021 | |
| Exeltis, USA INC. | $20.91 | 2024 | Slynd |
| Sumitomo Pharma America, INC. | $19.50 | 2023 | Myfembree |
| Novo Nordisk INC | $16.39 | 2024 | Rybelsus, Ozempic |
| Sage Therapeutics, LLC | $15.33 | 2024 | |
| Organon LLC | $12.68 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.